Published in Balsaenggwa Saengsig on December 01, 2015
Cancer risks from arsenic in drinking water. Environ Health Perspect (1992) 6.98
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med (1998) 6.83
Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum Suppl (1987) 6.47
Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect (2004) 5.19
Arsenic round the world: a review. Talanta (2002) 4.71
Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci (1998) 2.99
Arsenic groundwater contamination in Middle Ganga Plain, Bihar, India: a future danger? Environ Health Perspect (2003) 2.89
The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol (1998) 2.61
Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res (2003) 2.43
Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect (2001) 2.39
Arsenic exposure from drinking water and birth weight. Epidemiology (2003) 2.32
Health effects and risk assessment of arsenic. J Nutr (2003) 2.21
Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet (2007) 2.19
Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol (2003) 2.16
The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol (2001) 2.15
Public health. Arsenic epidemiology and drinking water standards. Science (2002) 2.14
Effects of arsenic on maternal and fetal health. Annu Rev Nutr (2009) 2.11
Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Am J Epidemiol (2008) 2.06
Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect (2000) 1.85
Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol (1997) 1.68
Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am J Epidemiol (2007) 1.67
Chronic arsenic exposure and adverse pregnancy outcomes in bangladesh. Epidemiology (2005) 1.60
Changes in the chemical speciation of arsenic following ingestion by man. Environ Health Perspect (1977) 1.59
A review on environmental factors regulating arsenic methylation in humans. Toxicol Appl Pharmacol (2008) 1.58
Liver is a target of arsenic carcinogenesis. Toxicol Sci (2008) 1.55
Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol Appl Pharmacol (2005) 1.52
Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol (2005) 1.51
Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ Health Perspect (2010) 1.51
Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect (2007) 1.49
Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem Res Toxicol (1997) 1.43
Epidemiologic evidence of diabetogenic effect of arsenic. Toxicol Lett (2002) 1.38
Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis (2003) 1.35
Arsenic in drinking water and adverse pregnancy outcome in an arseniasis-endemic area in northeastern Taiwan. Environ Res (2003) 1.34
Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem Res Toxicol (2001) 1.30
Stress hormone and male reproductive function. Cell Tissue Res (2005) 1.27
A hospital-based case-control study of stillbirths and environmental exposure to arsenic using an atmospheric dispersion model linked to a geographical information system. Epidemiology (1998) 1.27
Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit Rev Toxicol (2006) 1.27
Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin Cancer Res (2000) 1.26
Arsenic speciation and toxicity in biological systems. Rev Environ Contam Toxicol (2005) 1.23
Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action. Toxicol Appl Pharmacol (2000) 1.23
Airborne arsenic exposure and excretion of methylated arsenic compounds. Environ Health Perspect (1977) 1.19
Effects of chronic exposure to sodium arsenite on hypothalamo-pituitary-testicular activities in adult rats: possible an estrogenic mode of action. Reprod Biol Endocrinol (2006) 1.15
Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice. Toxicol Appl Pharmacol (1998) 1.14
Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J Toxicol Environ Health B Crit Rev (1998) 1.13
Male reproductive toxicity of sodium arsenite in mice. Hum Exp Toxicol (2004) 1.08
Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Toxicol Appl Pharmacol (2004) 1.08
Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol Teratol (2002) 1.07
Effect of sodium arsenite on spermatogenesis, plasma gonadotrophins and testosterone in rats. Asian J Androl (2003) 1.06
Effects of arsenic on younger generations. J Environ Sci Health A Tox Hazard Subst Environ Eng (2003) 1.05
Insights into the carcinogenic mode of action of arsenic. Toxicol Appl Pharmacol (2006) 1.01
Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur J Cancer (1999) 1.01
Some metals and metallic compounds. IARC Monogr Eval Carcinog Risk Chem Hum (1980) 1.00
Arsenic-induced toxicity and the protective role of ascorbic acid in mouse testis. Toxicol Appl Pharmacol (2006) 1.00
Pathologic changes in rats and dogs from two-year feeding of sodium arsenite or sodium arsenate. Toxicol Appl Pharmacol (1967) 0.98
Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol Lett (2002) 0.95
Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic. Teratology (2000) 0.93
Malformations induced by sodium arsenate. J Reprod Fertil (1968) 0.93
Pharmacokinetics, metabolism, and carcinogenicity of arsenic. Rev Environ Contam Toxicol (2001) 0.92
Reduction and binding of arsenate in marmoset monkeys. Arch Toxicol (1985) 0.92
Arsenic induced toxicity on testicular tissue of mice. Indian J Physiol Pharmacol (2008) 0.92
Environmental exposure to metals and male reproductive hormones: circulating testosterone is inversely associated with blood molybdenum. Fertil Steril (2008) 0.91
Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration. Teratology (1987) 0.91
Teratogenic effects of sodium arsenate in mice. Arch Environ Health (1972) 0.90
Accumulation of toxic metals in male reproduction organs. Arch Toxicol Suppl (1984) 0.90
In vivo reduction of arsenate in mice and rabbits. Environ Res (1983) 0.87
Polyneuropathy due to acute arsenic intoxication: biopsy studies. J Neuropathol Exp Neurol (1990) 0.87
Developmental toxicity of inorganic arsenic in whole embryo: culture oxidation state, dose, time, and gestational age dependence. Toxicol Appl Pharmacol (1996) 0.85
Is the human carcinogen arsenic carcinogenic to laboratory animals? Toxicol Sci (2000) 0.83
Absence of prenatal developmental toxicity from inhaled arsenic trioxide in rats. Toxicol Sci (1999) 0.83
Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution. Int J Hematol (1999) 0.83
Risk of erectile dysfunction induced by arsenic exposure through well water consumption in Taiwan. Environ Health Perspect (2008) 0.82
Effects of arsenic exposure during the pre- and postnatal development on the puberty of female offspring. Exp Toxicol Pathol (2010) 0.82
Evaluation of the prenatal developmental toxicity of orally administered arsenic trioxide in rats. Food Chem Toxicol (2000) 0.82
Arsenic trioxide-induced apoptosis in TM4 Sertoli cells: the potential involvement of p21 expression and p53 phosphorylation. Toxicology (2011) 0.82
Effect of sodium arsenite on plasma levels of gonadotrophins and ovarian steroidogenesis in mature albino rats: duration-dependent response. J Toxicol Sci (1999) 0.82
Male reproductive effect of arsenic in mice. Biometals (2001) 0.82
Urinary metabolic biomarkers link oxidative stress indicators associated with general arsenic exposure to male infertility in a han chinese population. Environ Sci Technol (2013) 0.81
Teratogen update: inorganic arsenic. Teratology (2001) 0.81
Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells. Toxicol Sci (2005) 0.81
The teratogenic potential of cacodylic acid in the rat and mouse. Drug Chem Toxicol (1981) 0.81
Effects of chemically induced maternal toxicity on prenatal development in the rat. Teratology (1990) 0.80
The effects of gestational arsenic exposure and dietary selenium deficiency on selenium and selenoenzymes in maternal and fetal tissues in mice. Toxicology (2005) 0.79
Effect of subacute low level dietary sodium arsenite on dogs. Fundam Appl Toxicol (1989) 0.79
Effects of corticosterone on the negative feedback action of testosterone, 5 alpha-dihydrotestosterone and estradiol in the adult male rat. J Steroid Biochem (1988) 0.78
Human sperm immobilizing activity of aminophenyl arsenic acid and its N-substituted quinazoline, pyrimidine, and purine derivatives: protective effect of glutathione. Reprod Toxicol (2002) 0.78
Fetotoxicity caused by the interaction between zinc and arsenic in mice. Teratog Carcinog Mutagen (2002) 0.78
Comparative effects of single intraperitoneal or oral doses of sodium arsenate or arsenic trioxide during in utero development. Teratology (1999) 0.77
Arsenic inhibits in vitro spermatogenesis and induces germ cell apoptosis in Japanese eel (Anguilla japonica). Reproduction (2009) 0.76